ID: ALA2315305

Max Phase: Preclinical

Molecular Formula: C11H14N2S2

Molecular Weight: 238.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)SSc1nc2ccccc2[nH]1

Standard InChI:  InChI=1S/C11H14N2S2/c1-11(2,3)15-14-10-12-8-6-4-5-7-9(8)13-10/h4-7H,1-3H3,(H,12,13)

Standard InChI Key:  JUGXHSUVCKNTAC-UHFFFAOYSA-N

Associated Targets(Human)

Thioredoxin 111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 238.38Molecular Weight (Monoisotopic): 238.0598AlogP: 4.10#Rotatable Bonds: 2
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.82CX Basic pKa: 3.67CX LogP: 3.91CX LogD: 3.91
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.80Np Likeness Score: -1.10

References

1. DiRaimondo TR, Plugis NM, Jin X, Khosla C..  (2013)  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.,  56  (3): [PMID:23327656] [10.1021/jm301775s]

Source